EYPT CIK: 1314102

EyePoint, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.24
FY22:
0.17
FY23:
0.34
FY24:
0.38
FY25:
0.33
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.01
FY23:
0.01
FY24:
0.04
FY25:
0.04
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.26
FY22:
0.18
FY23:
0.36
FY24:
0.42
FY25:
0.36

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.06
FY24:
0.05
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.06
FY22:
0.05
FY23:
0.03
FY24:
0.03
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.18
FY22:
0.10
FY23:
0.27
FY24:
0.34
FY25:
0.31
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.26
FY22:
0.18
FY23:
0.36
FY24:
0.42
FY25:
0.36

All amounts in billions USD Data source:SEC EDGAR